Supportive Care in Cancer

, Volume 8, Issue 2, pp 89–97

Psychopharmacology in supportive care of cancer: a review for the clinician

II. Neuroleptics
  • C. Mazzocato
  • F. Stiefel
  • T. Buclin
  • A. Berney
REVIEW ARTICLE

DOI: 10.1007/s005200050021

Cite this article as:
Mazzocato, C., Stiefel, F., Buclin, T. et al. Support Care Cancer (2000) 8: 89. doi:10.1007/s005200050021

Abstract

 Neuroleptics are frequently used in patients with advanced cancer. Most relevant and practical aspects of their use in supportive cancer care are reviewed, to assist the clinical oncologist and palliative care specialist when prescribing these drugs. This article reviews pharmacological properties, indications, such as delirium, nausea and vomiting, pain, anxiety and other symptoms, adverse effects, and drug interactions of neuroleptics and compares the profiles of different compounds. Special emphasis is put on the role of neuroleptics in the management of delirium.

Key words Neuroleptics Cancer Palliative care Delirium Psychotropics 

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • C. Mazzocato
    • 1
  • F. Stiefel
    • 1
  • T. Buclin
    • 3
  • A. Berney
    • 2
  1. 1.Division de soins palliatifs, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, SwitzerlandCH
  2. 2.Service de psychiatrie de liaison, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland Tel.: +41-21-3141090 Fax: +41-21-3141098CH
  3. 3.Division de pharmacologie clinique, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, SwitzerlandCH

Personalised recommendations